Zebra Capital Management LLC Lantheus Holdings, Inc. Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$18.47 - $24.03 $272,118 - $354,033	-14,733 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $8,530 - $11,749	-406 Reduced 2.68%	14,733 $369,000
Q2 2019 Aug 14, 2019	SELL	$23.33 - $28.3 $123,089 - $149,310	-5,276 Reduced 25.84%	15,139 $428,000
Q1 2019 May 15, 2019	SELL	$14.93 - $25.1 $110,198 - $185,263	-7,381 Reduced 26.55%	20,415 $500,000
Q4 2018 Feb 14, 2019	SELL	$12.68 - $19.01 $39,929 - $59,862	-3,149 Reduced 10.18%	27,796 $435,000
Q3 2018 Nov 14, 2018	BUY	$13.1 - $16.35 $405,379 - $505,950	30,945 New	30,945 $463,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.25B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.